Effect of Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase 4 Inhibitors on Cardiovascular Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease

BACKGROUND: Randomized controlled trials demonstrated lowering risks of cardiovascular events with sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM) and high cardiovascular risk. We analyzed the effects of cardiovascular function on SGLT2 inhibitors c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sook Jung, Lee, Kook Hyung, Oh, Hyun Geong, Seo, Hye Ji, Jeong, Soo Jin, Kim, Chong Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for the Study of Obesity 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939702/
https://www.ncbi.nlm.nih.gov/pubmed/31909368
http://dx.doi.org/10.7570/jomes.2019.28.4.254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939702/
https://www.ncbi.nlm.nih.gov/pubmed/31909368
http://dx.doi.org/10.7570/jomes.2019.28.4.254

Ejemplares similares